Iressa Tablets 250, manufactured by AstraZeneca (YJ code: 4291013F1027, standard: 250mg x 1 tablet), contain gefitinib, a tyrosine kinase inhibitor used for the first-line treatment of metastatic non-small cell lung cancer with specific EGFR mutations.
Iressa Tablets 250
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
